John Crowley's life changes when his two children are diagnosed with a rare neuromuscular disease that doctors predict will end their lives within a year. With no medical background, Crowley throws himself headfirst into finding a cure for the disease, starting a biotech company that aims to save the lives of his own children and others with the same condition.